Related Experiment Videos

Paediatric homoeopathy in general practice: where, when and why?

Suzie Ekins-Daukes1, Peter J Helms, Michael W Taylor

  • 1Department of Medicine and Therapeutics, The University of Aberdeen, Polwarth Buildings, Foresterhill, Aberdeen, AB25 2ZD.

Insights

Homoeopathic medicines are prescribed to children in primary care, mainly for self-limiting infant conditions. GPs interested in homoeopathy, with training, are more likely to prescribe it, often when conventional treatments fail.

Area of Science:

  • Integrative Medicine
  • Paediatric Healthcare
  • General Practice Research

Background:

  • Homoeopathy is a complementary therapy with varying acceptance in conventional medicine.
  • Understanding its use in primary care for children is crucial for evidence-based practice.

Purpose of the Study:

  • To quantify homoeopathic medicine prescribing for children in Scottish primary care.
  • To evaluate general practitioners' (GPs) attitudes towards homoeopathic prescribing in paediatric patients.

Main Methods:

  • Analysis of prescribing data for 167,865 children (0-16 years) in 161 Scottish general practices (1999-2000).
  • A questionnaire survey assessed GPs' attitudes, training, and reasons for prescribing or not prescribing homoeopathy.

Main Results:

  • 22% of practices prescribed homoeopathic medicines to 1.1/1000 children, primarily infants under one year for self-limiting conditions.
  • Frequent prescribers showed interest, training, and positive attitudes towards homoeopathy, often using it when conventional treatments failed.
  • Lack of efficacy and training were key reasons for non-prescribing, though some non-prescribers in prescribing practices were more open to future use.

Conclusions:

  • Homoeopathic prescribing in primary care is concentrated among infants for common, self-limiting ailments.
  • Despite low overall rates, community use indicates a need for GPs to be informed about homoeopathy's indications and preparations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...